search
Back to results

Anterior Wedge in Patients With Osteoarthritis Hip

Primary Purpose

Gait, Frontal

Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Application of the anterior wedge
Sponsored by
Faculdade de Ciências Médicas da Santa Casa de São Paulo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gait, Frontal

Eligibility Criteria

50 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Sedentary individuals
  • Both genders
  • Age equal to or greather than 50 years
  • Diagnosis of osteoarthritis level II and III

Exclusion Criteria:

  • fractures
  • Neuromuscular diseases
  • Other diseases of hip

Sites / Locations

  • Flávia Nakatake

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control Group

Experimental group

Arm Description

Patient will undergo gait analysis

Patient will undergo gait analysis with use of anterior wedge

Outcomes

Primary Outcome Measures

Inproved performance of the gluteus maximus
Extent moment will be assessed by gait analysis

Secondary Outcome Measures

Full Information

First Posted
January 3, 2018
Last Updated
February 25, 2019
Sponsor
Faculdade de Ciências Médicas da Santa Casa de São Paulo
search

1. Study Identification

Unique Protocol Identification Number
NCT03393923
Brief Title
Anterior Wedge in Patients With Osteoarthritis Hip
Official Title
Effect of Anterior Wedge Use in Patients With Osteoarthritis Hip
Study Type
Interventional

2. Study Status

Record Verification Date
January 2017
Overall Recruitment Status
Completed
Study Start Date
July 10, 2017 (Actual)
Primary Completion Date
January 1, 2018 (Actual)
Study Completion Date
December 10, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Faculdade de Ciências Médicas da Santa Casa de São Paulo

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Ostearthritis is a great source of pain. In symptomatic hip the pain can lead the major disability and poor quality of life. Understand the musculoskeletal factores can lead to a better clinical management. The muscle strenghening of posterolateral complexo of hip is a important consideration. General Objective: Perform a Kinetic analysis 2D using na anterior wedge. Specific objective: Analyze the influence of posterolateral hip complex. Controlled clinical trial, composed by 30 individuals with and without osteoarthritis of hip e will be used a tools; Analogic Visual Scale, manual dynamometry to analyze force and kinetic analyze of gait through of Myovídeo analysis software.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gait, Frontal

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Non-Randomized
Enrollment
18 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Patient will undergo gait analysis
Arm Title
Experimental group
Arm Type
Experimental
Arm Description
Patient will undergo gait analysis with use of anterior wedge
Intervention Type
Other
Intervention Name(s)
Application of the anterior wedge
Intervention Description
Application of anterior wedge in tennis
Primary Outcome Measure Information:
Title
Inproved performance of the gluteus maximus
Description
Extent moment will be assessed by gait analysis
Time Frame
24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Sedentary individuals Both genders Age equal to or greather than 50 years Diagnosis of osteoarthritis level II and III Exclusion Criteria: fractures Neuromuscular diseases Other diseases of hip
Facility Information:
Facility Name
Flávia Nakatake
City
São Paulo
ZIP/Postal Code
03918000
Country
Brazil

12. IPD Sharing Statement

Learn more about this trial

Anterior Wedge in Patients With Osteoarthritis Hip

We'll reach out to this number within 24 hrs